AI Firewall Launch And Steady Guidance Might Change The Case For Investing In Check Point (CHKP)

• In late July 2026, Check Point Software Technologies reported second-quarter results with revenue of US$673.6 million and launched its AI Network Firewall within the R82.20 software release, while also providing third-quarter 2026 revenue guidance of US$665 million to US$685 million and maintaining full-year guidance.
• The combination of a new AI Defense Plane, continued share repurchases totaling about US$12.43 billion since 2016, and steady subscription growth signals how Check Point is reshaping its security portfolio and capital allocation as AI-related cyber risks accelerate.
• We’ll now examine how Check Point’s launch of the AI Network Firewall and reaffirmed guidance influence its existing investment narrative.

Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

Check Point Software Technologies Investment Narrative Recap

To own Check Point today, you need to believe that its shift toward higher value subscriptions and AI centric security can offset cooling demand for traditional firewall hardware. The latest quarter’s modest revenue growth, reaffirmed 2026 guidance and continued buybacks suggest the near term catalyst is execution on this subscription mix shift, while the biggest current risk remains margin pressure from competition in SASE and AI security. The new AI Network Firewall does not materially change that risk, but it does sharpen the story.

The AI Network Firewall launch is the clearest link between Check Point’s existing firewall base and its newer AI Defense Plane ambitions. By delivering AI security through R82.20 software on installed firewalls, Check Point is trying to deepen relevance with existing customers and support subscription growth tied to real world AI use cases, which matters directly to how investors think about its ability to grow recurring revenue without relying on large new appliance cycles.

Yet despite this, investors should still be aware that competitive pressure in SASE and AI security could...

Read the full narrative on Check Point Software Technologies (it's free!)

Check Point Software Technologies' narrative projects $3.3 billion revenue and $988.7 million earnings by 2029. This requires 6.1% yearly revenue growth and an earnings decrease of about $111 million from $1.1 billion today.

Uncover how Check Point Software Technologies' forecasts yield a $144.32 fair value, a 13% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts already expected Check Point to reach about US$3.4 billion in revenue and US$1.2 billion in earnings by 2029, assuming AI security, exposure management and other new pillars scale quickly. After the AI Network Firewall launch, you may find that these higher expectations look either more realistic or too aggressive, so it is worth comparing how your own view of the product news lines up with those bullish forecasts and where you sit on that spectrum.

Explore 3 other fair value estimates on Check Point Software Technologies - why the stock might be worth just $144.32!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Check Point Software Technologies research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Check Point Software Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Check Point Software Technologies' overall financial health at a glance.

Searching For A Fresh Perspective?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 52 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com